DK2083016T3 - Bakterielle superantigenvacciner - Google Patents

Bakterielle superantigenvacciner

Info

Publication number
DK2083016T3
DK2083016T3 DK09001558.7T DK09001558T DK2083016T3 DK 2083016 T3 DK2083016 T3 DK 2083016T3 DK 09001558 T DK09001558 T DK 09001558T DK 2083016 T3 DK2083016 T3 DK 2083016T3
Authority
DK
Denmark
Prior art keywords
superantigen
spea
altered
vaccines
attenuated
Prior art date
Application number
DK09001558.7T
Other languages
English (en)
Inventor
Robert G Ulrich
Original Assignee
U S Medical Res Inst Of Infectious Diseases
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U S Medical Res Inst Of Infectious Diseases filed Critical U S Medical Res Inst Of Infectious Diseases
Application granted granted Critical
Publication of DK2083016T3 publication Critical patent/DK2083016T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK09001558.7T 2001-11-26 2001-11-26 Bakterielle superantigenvacciner DK2083016T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2001/046540 WO2003056015A1 (en) 2001-11-26 2001-11-26 Bacterial superantigen vaccines
EP01996119A EP1461433A1 (en) 2001-11-26 2001-11-26 Bacterial superantigen vaccines

Publications (1)

Publication Number Publication Date
DK2083016T3 true DK2083016T3 (da) 2011-10-03

Family

ID=21743073

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09001558.7T DK2083016T3 (da) 2001-11-26 2001-11-26 Bakterielle superantigenvacciner

Country Status (6)

Country Link
EP (2) EP2083016B1 (da)
AT (1) ATE512978T1 (da)
AU (1) AU2002227232A1 (da)
CA (1) CA2506538C (da)
DK (1) DK2083016T3 (da)
WO (1) WO2003056015A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
CA3069747A1 (en) 2017-07-27 2019-01-31 Mohammad Javad Aman Immunogenic composition comprising a fusion peptide derived from superantigen toxoids
US20230104241A1 (en) * 2020-12-18 2023-04-06 Biomedizinische Forschung & Bio-Produkte AG Protective staphylococcal exotoxin vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6555494A (en) * 1993-04-05 1994-10-24 National Jewish Center For Immunology And Respiratory Medicine Method for treating kawasaki syndrome via immune modulation
WO1996014744A1 (en) * 1994-11-14 1996-05-23 National Jewish Center For Immunology And Respiratory Medicine Protective effects of mutated superantigens
KR100548663B1 (ko) * 1996-12-06 2006-02-03 리전츠 오브 더 유니버스티 오브 미네소타 연쇄상구균 독소 ａ의 돌연변이체
MXPA01001631A (es) * 1998-08-13 2002-04-08 Walter Reed Army Inst Of Res D Vacunas de superantigenos bacterianos.

Also Published As

Publication number Publication date
AU2002227232A1 (en) 2003-07-15
CA2506538C (en) 2013-07-09
ATE512978T1 (de) 2011-07-15
CA2506538A1 (en) 2003-07-10
EP2083016A1 (en) 2009-07-29
WO2003056015A1 (en) 2003-07-10
EP2083016B1 (en) 2011-06-15
EP1461433A1 (en) 2004-09-29

Similar Documents

Publication Publication Date Title
EP1545597A4 (en) IMMUNOSTIMULANT COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
ATE426412T1 (de) Adjuvante influenza-vakzine
MY149604A (en) C.perfringens alpha toxoid vaccine
DK1354034T3 (da) Transgene transchromosomale gnavere til fremstilling af humane antistoffer
CY1112325T1 (el) Ανοσολογικες εφαρμογες ανοσοτροποποιητικων ενωσεων για εμβολια και αντι-μικροβιακες θεραπειες
TR200704553T2 (tr) Streptokok antijenleri.
DE69713408D1 (de) Streptococcus equi Impstoff
ATE426026T1 (de) Chimare arterivirus-ahnliche partikel
ATE542829T1 (de) Impfstoff
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
EA200702254A1 (ru) Вакцинная композиция, содержащая в-субъединицу термолабильного токсина e.coli и антиген и адъювант
DK1461054T3 (da) Gram-positive bakteriepræparater til behandling af sygdomme omfattende en immundysregulering
ATE375804T1 (de) Ribavirin-enthaltende vakzine
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
ATE412750T1 (de) Antigen aus streptococcus pyogenes
DK2083016T3 (da) Bakterielle superantigenvacciner
ATE195878T1 (de) Toxine und toxoide von clostridium difficile als schleimhautadjuvans
WO2003097089A3 (de) Attenuierung von metapneumovirus
ATE310008T1 (de) Immunologische adjuvans verbindungen
ATE392209T1 (de) Apikomplex-vakzine-stämme einer familie von sarcocystidae
DK0946730T3 (da) Mutanter af streptokok-toksin C og fremgangsmåder til anvendelse
ATE484744T1 (de) Impfstoffe die gegen streptococcus pneumonia infektionen schützen.
WO2003093416A3 (en) Protective antigens for the control of ixodes species infestations
ATE515270T1 (de) Phep, eine aminosäurepermease von staphylococcus aureus
ATE505482T1 (de) Impfstoff gegen infektiöses lachsanämievirus